Viewing Study NCT02126761


Ignite Creation Date: 2025-12-24 @ 1:04 PM
Ignite Modification Date: 2026-01-26 @ 12:06 AM
Study NCT ID: NCT02126761
Status: COMPLETED
Last Update Posted: 2016-07-29
First Post: 2014-04-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Immunogenicity of Different Formulations of an Adjuvanted, Trivalent Subunit Influenza Vaccine in Elderly Subjects 65 Years of Age and Above
Sponsor: Seqirus
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Influenza View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Influenza View
None elderly View
None adjuvant View